Furthermore, a microarray analysis of PRAME shRNA-silenced leukemic cells revealed that PRAME alters the expression of two additional genes, IL-8 and IGFBP2, that are potentially involved in carcinogenesis and cancer progression. The gene discussed is PRAME; the disease is cancer.